Companies
/
Virta Health
Healthtech
Virta Health is a San Francisco-based virtual care company that treats type 2 diabetes and other metabolic conditions primarily through nutritional intervention, particularly a carbohydrate-restricted diet, rather than medication alone.
Create an account to view live offerings, pricing, and market activity.
Sign in to view offerings and live market activity.
Virta Health was founded in 2014 by Sami Inkinen and provides virtual care for people with type 2 diabetes and other metabolic conditions. Its approach combines physician oversight, health coaching, continuous biomarker monitoring, and a carbohydrate-restricted nutritional program. The company has published clinical research examining the effects of its approach on diabetes-related biomarkers, medication use, and remission outcomes. Virta's platform provides virtual care combining physician oversight, health coaching, and continuous biomarker monitoring to help patients safely implement and sustain this carbohydrate-restricted dietary approach, with particularly close medical monitoring important given that patients on diabetes medications, including insulin, need careful medical supervision as their blood sugar control potentially improves substantially through the dietary intervention, since medication doses that were previously appropriate could become dangerously high once a patient's underlying blood sugar control improves, creating risk of dangerously low blood sugar (hypoglycemia) without proper medical oversight and medication adjustment as a patient's diet-driven improvement in blood sugar control progresses. The company has published clinical research studies evaluating its approach's effectiveness at improving diabetes-related biomarkers and, for some patients, achieving diabetes remission or substantially reduced medication needs, building a clinical evidence base intended to support its approach's legitimacy and effectiveness relative to more skeptical views some clinicians have historically held toward very low-carbohydrate dietary approaches for diabetes management. Virta's primary go-to-market model involves partnering with employers and health plans, who cover the cost of the Virta program for eligible members given the potential for significant downstream healthcare cost savings if the program successfully reduces members' diabetes-related medication needs and complications. The company has raised very substantial venture funding from investors including Sequoia Capital, Threshold Ventures, and Menlo Ventures, reaching a valuation exceeding $2 billion.
FOR QUALIFIED INSTITUTIONAL AND ACCREDITED INVESTORS ONLY: Under federal securities laws, private market investments on this platform are available exclusively to Institutional and Accredited Investors. Verification of status required before investing. Private investments involve significant risks including illiquidity, potential loss of principal, and limited disclosure requirements. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, not a bank or financial institution. Cash Accounts are provided by Modern Treasury Corp. financial institution partners and through Augment's technology. Augment does not act as a money services business, provide money transmission, or serve as a custodian of funds. Funds held in your Cash Account are not FDIC insured unless expressly disclosed. Full terms available in the Augment Cash Account Agreement. Brokerage services are offered through Augment Capital, LLC, an affiliated broker-dealer and member FINRA/SIPC. "Investment accounts" are not brokerage accounts and do not hold customer funds or securities. Investment advisory services are offered through Augment Advisors, LLC, an SEC-registered investment adviser. Registration with the SEC does not imply a certain level of skill or training. Neither Augment Advisors, LLC nor Augment Capital, LLC provide legal or tax advice; consult your attorney or tax professional regarding your specific situation. For additional information, please refer to Augment Advisors, LLC's Form ADV Part 2A (Firm Brochure) and FINRA BrokerCheck.
